PharmaCyte Going Hea
PharmaCyte Going Head to Head with Eli Lilly's Pancreatic Cancer Drug in New Clinical Trial
24 janv. 2017 09h10 HE | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - January 24, 2017) - Ten years ago the National Cancer Institute (NCI) recognized the rise in pancreatic cancer deaths and called for the development of better treatments....
Greenridge Global Is
Greenridge Global Issues Research Report with Buy Rating and $3 Price Target on Staffing 360 Solutions, Inc.
19 janv. 2017 08h00 HE | Staffing 360 Solutions, Inc.
NEW YORK, NY--(Marketwired - January 19, 2017) - Staffing 360 Solutions, Inc. (NASDAQ: STAF), an international staffing services provider, announced its fiscal second quarter numbers last week, and...
Live Ventures Hits $
Live Ventures Hits $79-Million in Revenues While Company Expects to Surpass $120-Million in 2017
29 déc. 2016 08h30 HE | Live Ventures Incorporated
NEW YORK, NY--(Marketwired - December 29, 2016) - Live Ventures, Inc. (NASDAQ: LIVE) released its financials for fiscal year-end (YE) 2016, and the company announced record revenues of almost...
PharmaCyte Biotech S
PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
12 déc. 2016 09h00 HE | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 12, 2016) - All of the pieces are starting to fall into place for PharmaCyte Biotech (OTCQB: PMCB) and its upcoming human clinical trial in advanced pancreatic...
PharmaCyte Biotech M
PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial
01 déc. 2016 09h00 HE | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - December 01, 2016) - PharmaCyte Biotech (OTCQB: PMCB) is now one step closer to enrolling patients in a pivotal clinic trial in advanced, inoperable pancreatic cancer...
SPYR's Role-Playing,
SPYR's Role-Playing, Strategy Game, Pocket Starships, A Part of Most Lucrative Mobile Game Genres
29 nov. 2016 09h15 HE | SPYR, Inc.
NEW YORK, NY --(Marketwired - November 29, 2016) - When it comes to mobile games, SPYR, Inc.'s (OTCQB: SPYR) flagship MMO game, Pocket Starships, falls into all the right categories for revenue...
SPYR Targets Worldwi
SPYR Targets Worldwide Audience for Pocket Starships as Asian Market Continues Solid Growth
17 nov. 2016 09h15 HE | SPYR, Inc.
NEW YORK, NY--(Marketwired - November 17, 2016) - In 2016, the global games market grew to almost $100 billion according to Newzoo's Global Games Market Report. In that report, China and the...
PharmaCyte Biotech N
PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial
16 nov. 2016 09h15 HE | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - November 16, 2016) - PharmaCyte Biotech (OTCQB: PMCB) has arrived at the door of U.S. FDA and awaits a pre-IND meeting with the agency. After years of surrounding its...
SPYR Executive Discu
SPYR Executive Discusses Company's Future in Mobile eSports
04 nov. 2016 09h15 HE | SPYR, Inc.
NEW YORK, NY--(Marketwired - November 04, 2016) - At the end of October, SPYR, Inc. (OTCQB: SPYR) added Mike Turner, a video game industry expert, to its team as its VP of Strategic Partnerships....
SPYR Outperforming P
SPYR Outperforming Projections With Fundamental Approach to Driving Growth
13 oct. 2016 09h15 HE | SPYR, Inc.
NEW YORK, NY--(Marketwired - October 13, 2016) - SPYR, Inc. (OTCQB: SPYR) has exceeded its own early projections in the company's marketing and advertising campaign for its flagship MMO game Pocket...